Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.

Guan M, Keaton JM, Dimitrov L, Hicks PJ, Xu J, Palmer ND, Ma L, Das SK, Chen YI, Coresh J, Fornage M, Franceschini N, Kramer H, Langefeld CD, Mychaleckyj JC, Parekh RS, Post WS, Rasmussen-Torvik LJ, Rich SS, Rotter JI, Sedor JR, Thornley-Brown D, Tin A, Wilson JG, Freedman BI, Bowden DW, Ng MCY; FIND Consortium.

Hum Genomics. 2019 May 15;13(1):21. doi: 10.1186/s40246-019-0205-7.

2.

Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.

Pollack S, Igo RP Jr, Jensen RA, Christiansen M, Li X, Cheng CY, Ng MCY, Smith AV, Rossin EJ, Segrè AV, Davoudi S, Tan GS, Chen YI, Kuo JZ, Dimitrov LM, Stanwyck LK, Meng W, Hosseini SM, Imamura M, Nousome D, Kim J, Hai Y, Jia Y, Ahn J, Leong A, Shah K, Park KH, Guo X, Ipp E, Taylor KD, Adler SG, Sedor JR, Freedman BI; Family Investigation of Nephropathy and Diabetes-Eye Research Group, DCCT/EDIC Research Group, Lee IT, Sheu WH, Kubo M, Takahashi A, Hadjadj S, Marre M, Tregouet DA, Mckean-Cowdin R, Varma R, McCarthy MI, Groop L, Ahlqvist E, Lyssenko V, Agardh E, Morris A, Doney ASF, Colhoun HM, Toppila I, Sandholm N, Groop PH, Maeda S, Hanis CL, Penman A, Chen CJ, Hancock H, Mitchell P, Craig JE, Chew EY, Paterson AD, Grassi MA, Palmer C, Bowden DW, Yaspan BL, Siscovick D, Cotch MF, Wang JJ, Burdon KP, Wong TY, Klein BEK, Klein R, Rotter JI, Iyengar SK, Price AL, Sobrin L.

Diabetes. 2019 Feb;68(2):441-456. doi: 10.2337/db18-0567. Epub 2018 Nov 28.

PMID:
30487263
3.

APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?

Bruggeman LA, O'Toole JF, Sedor JR.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F1-F8. doi: 10.1152/ajprenal.00426.2018. Epub 2018 Oct 17.

PMID:
30332315
4.

Dramatic secular changes in prognosis for kidney transplant candidates in the United States.

Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED.

Am J Transplant. 2019 Feb;19(2):414-424. doi: 10.1111/ajt.15021. Epub 2018 Aug 14.

PMID:
30019832
5.

Willingness to Participate in a National Precision Medicine Cohort: Attitudes of Chronic Kidney Disease Patients at a Cleveland Public Hospital.

Cooke Bailey JN, Crawford DC, Goldenberg A, Slaven A, Pencak J, Schachere M, Bush WS, Sedor JR, O'Toole JF.

J Pers Med. 2018 Jun 26;8(3). pii: E21. doi: 10.3390/jpm8030021.

6.

Somatic T-cell Receptor Diversity in a Chronic Kidney Disease PatientPopulation Linked to Electronic Health Records.

Crawford DC, Bailey JNC, Miskimen K, Miron P, McCauley JL, Sedor JR, ƠToole JF, Bush WS.

AMIA Jt Summits Transl Sci Proc. 2018 May 18;2017:63-71. eCollection 2018.

7.

CKD, Genetic Variation, and the Epigenome: Decrypting the Code.

O'Toole JF, Sedor JR.

Am J Kidney Dis. 2018 Aug;72(2):164-167. doi: 10.1053/j.ajkd.2018.03.012. Epub 2018 May 2. No abstract available.

PMID:
29728315
8.

Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States.

Schold JD, Flechner SM, Poggio ED, Augustine JJ, Goldfarb DA, Sedor JR, Buccini LD.

Am J Kidney Dis. 2018 Jul;72(1):19-29. doi: 10.1053/j.ajkd.2017.12.014. Epub 2018 Mar 7.

PMID:
29525324
9.

ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.

O'Toole JF, Schilling W, Kunze D, Madhavan SM, Konieczkowski M, Gu Y, Luo L, Wu Z, Bruggeman LA, Sedor JR.

J Am Soc Nephrol. 2018 Mar;29(3):869-879. doi: 10.1681/ASN.2016121322. Epub 2017 Nov 27.

10.

The Cell Biology of APOL1.

O'Toole JF, Bruggeman LA, Madhavan S, Sedor JR.

Semin Nephrol. 2017 Nov;37(6):538-545. doi: 10.1016/j.semnephrol.2017.07.007. Review.

11.

APOL1 and Proteinuria in the AASK: Unraveling the Pathobiology of APOL1.

O'Toole JF, Bruggeman LA, Sedor JR.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1723-1725. doi: 10.2215/CJN.10680917. Epub 2017 Oct 19. No abstract available.

12.

A New Mouse Model of APOL1-Associated Kidney Diseases: When Traffic Gets Snarled, the Podocyte Suffers.

O'Toole JF, Bruggeman LA, Sedor JR.

Am J Kidney Dis. 2017 Oct;70(4):460-463. doi: 10.1053/j.ajkd.2017.07.002. Epub 2017 Aug 9. No abstract available.

PMID:
28801123
13.

APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial.

Freedman BI, Rocco MV, Bates JT, Chonchol M, Hawfield AT, Lash JP, Papademetriou V, Sedor JR, Servilla K, Kimmel PL, Wall BM, Pajewski NM; SPRINT Research Group.

Kidney Int Rep. 2017 Jul;2(4):713-720. doi: 10.1016/j.ekir.2017.03.008. Epub 2017 Mar 31.

14.

APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.

Madhavan SM, O'Toole JF, Konieczkowski M, Barisoni L, Thomas DB, Ganesan S, Bruggeman LA, Buck M, Sedor JR.

JCI Insight. 2017 Jul 20;2(14). pii: 92581. doi: 10.1172/jci.insight.92581. eCollection 2017 Jul 20.

15.

Building an Ideal Quality Metric for ESRD Health Care Delivery.

Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1351-1356. doi: 10.2215/CJN.01020117. Epub 2017 May 17. No abstract available.

16.

Identifying the Intracellular Function of APOL1.

Bruggeman LA, O'Toole JF, Sedor JR.

J Am Soc Nephrol. 2017 Apr;28(4):1008-1011. doi: 10.1681/ASN.2016111262. Epub 2017 Feb 14. No abstract available.

17.

α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.

Zhao X, Khurana S, Charkraborty S, Tian Y, Sedor JR, Bruggman LA, Kao HY.

J Biol Chem. 2017 Feb 3;292(5):1637-1647. doi: 10.1074/jbc.M116.755546. Epub 2016 Dec 20.

18.

Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.

Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, Zhang H, Lin C, Qi NR, Michailidis G, Groop PH, Nelson RG, Darshi M, Sharma K, Schelling JR, Sedor JR, Pop-Busui R, Weinberg JM, Soleimanpour SA, Abcouwer SF, Gardner TW, Burant CF, Feldman EL, Kretzler M, Brosius FC 3rd, Pennathur S.

JCI Insight. 2016 Sep 22;1(15):e86976. doi: 10.1172/jci.insight.86976.

19.

Glomerular Diseases: Registries and Clinical Trials.

Moxey-Mims MM, Flessner MF, Holzman L, Kaskel F, Sedor JR, Smoyer WE, Thompson AM, Yao L.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2234-2243. Epub 2016 Sep 26.

20.

APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.

Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R, Sethna CB, Kopp JB, Moxey-Mims M, Furth SL, Warady BA, Kretzler M, Sedor JR, Kaskel FJ, Sampson MG.

Nephrol Dial Transplant. 2017 Jun 1;32(6):983-990. doi: 10.1093/ndt/gfw061.

21.

Selecting SNPs informative for African, American Indian and European Ancestry: application to the Family Investigation of Nephropathy and Diabetes (FIND).

Williams RC, Elston RC, Kumar P, Knowler WC, Abboud HE, Adler S, Bowden DW, Divers J, Freedman BI, Igo RP Jr, Ipp E, Iyengar SK, Kimmel PL, Klag MJ, Kohn O, Langefeld CD, Leehey DJ, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Rotter JI, Schelling JR, Sedor JR, Shah VO, Smith MW, Taylor KD, Thameem F, Thornley-Brown D, Winkler CA, Guo X, Zager P, Hanson RL; FIND Research Group.

BMC Genomics. 2016 May 4;17:325. doi: 10.1186/s12864-016-2654-x.

22.

APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Bruggeman LA, Wu Z, Luo L, Madhavan SM, Konieczkowski M, Drawz PE, Thomas DB, Barisoni L, Sedor JR, O'Toole JF.

J Am Soc Nephrol. 2016 Dec;27(12):3600-3610. Epub 2016 Mar 29.

23.

Federal Funding for Kidney Disease Research: A Missed Opportunity.

Mendu ML, Erickson KF, Hostetter TH, Winkelmayer WC, Olan G, Meyer RN, Hakim R, Sedor JR.

Am J Public Health. 2016 Mar;106(3):406-7. doi: 10.2105/AJPH.2015.303009. No abstract available.

24.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

25.

Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).

Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, Keller BJ, Abboud HE, Adler SG, Best LG, Bowden DW, Burlock A, Chen YD, Cole SA, Comeau ME, Curtis JM, Divers J, Drechsler C, Duggirala R, Elston RC, Guo X, Huang H, Hoffmann MM, Howard BV, Ipp E, Kimmel PL, Klag MJ, Knowler WC, Kohn OF, Leak TS, Leehey DJ, Li M, Malhotra A, März W, Nair V, Nelson RG, Nicholas SB, O'Brien SJ, Pahl MV, Parekh RS, Pezzolesi MG, Rasooly RS, Rotimi CN, Rotter JI, Schelling JR, Seldin MF, Shah VO, Smiles AM, Smith MW, Taylor KD, Thameem F, Thornley-Brown DP, Truitt BJ, Wanner C, Weil EJ, Winkler CA, Zager PG, Igo RP Jr, Hanson RL, Langefeld CD; Family Investigation of Nephropathy and Diabetes (FIND).

PLoS Genet. 2015 Aug 25;11(8):e1005352. doi: 10.1371/journal.pgen.1005352. eCollection 2015 Aug.

26.

Introduction: Precision Medicine for Glomerular Disease: The Road Forward.

Kretzler M, Sedor JR.

Semin Nephrol. 2015 May;35(3):209-11. doi: 10.1016/j.semnephrol.2015.04.001. No abstract available.

27.

Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.

Sampson MG, Robertson CC, Martini S, Mariani LH, Lemley KV, Gillies CE, Otto EA, Kopp JB, Randolph A, Vega-Warner V, Eichinger F, Nair V, Gipson DS, Cattran DC, Johnstone DB, O'Toole JF, Bagnasco SM, Song PX, Barisoni L, Troost JP, Kretzler M, Sedor JR; Nephrotic Syndrome Study Network.

J Am Soc Nephrol. 2016 Mar;27(3):814-23. doi: 10.1681/ASN.2014111131. Epub 2015 Jul 6.

28.

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group.

Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12.

PMID:
26087670
29.

Patients as stakeholders in setting kidney disease research priorities.

Navaneethan SD, Boulware LE, Sedor JR.

Am J Kidney Dis. 2015 May;65(5):641-3. doi: 10.1053/j.ajkd.2015.01.015. No abstract available.

PMID:
25919496
30.

Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing.

Shah A, Miller CJ, Nast CC, Adams MD, Truitt B, Tayek JA, Tong L, Mehtani P, Monteon F, Sedor JR, Clinkenbeard EL, White K, Mehrotra R, LaPage J, Dickson P, Adler SG, Iyengar SK.

Nephrol Dial Transplant. 2014 Dec;29(12):2235-43. doi: 10.1093/ndt/gfu324. Epub 2014 Nov 5.

31.

The kidney research national dialogue: gearing up to move forward.

Bonventre JV, Boulware LE, Dember LM, Freedman BI, Furth SL, Holzman LB, Ketchum CJ, Little MH, Mehrotra R, Moe SM, Sands JM, Sedor JR, Somlo S, Star RA, Rys-Sikora KE; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1806-11. doi: 10.2215/CJN.07310714. Epub 2014 Sep 15. Review.

32.

Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes.

Ng MC, Shriner D, Chen BH, Li J, Chen WM, Guo X, Liu J, Bielinski SJ, Yanek LR, Nalls MA, Comeau ME, Rasmussen-Torvik LJ, Jensen RA, Evans DS, Sun YV, An P, Patel SR, Lu Y, Long J, Armstrong LL, Wagenknecht L, Yang L, Snively BM, Palmer ND, Mudgal P, Langefeld CD, Keene KL, Freedman BI, Mychaleckyj JC, Nayak U, Raffel LJ, Goodarzi MO, Chen YD, Taylor HA Jr, Correa A, Sims M, Couper D, Pankow JS, Boerwinkle E, Adeyemo A, Doumatey A, Chen G, Mathias RA, Vaidya D, Singleton AB, Zonderman AB, Igo RP Jr, Sedor JR; FIND Consortium, Kabagambe EK, Siscovick DS, McKnight B, Rice K, Liu Y, Hsueh WC, Zhao W, Bielak LF, Kraja A, Province MA, Bottinger EP, Gottesman O, Cai Q, Zheng W, Blot WJ, Lowe WL, Pacheco JA, Crawford DC; eMERGE Consortium; DIAGRAM Consortium, Grundberg E; MuTHER Consortium, Rich SS, Hayes MG, Shu XO, Loos RJ, Borecki IB, Peyser PA, Cummings SR, Psaty BM, Fornage M, Iyengar SK, Evans MK, Becker DM, Kao WH, Wilson JG, Rotter JI, Sale MM, Liu S, Rotimi CN, Bowden DW; MEta-analysis of type 2 DIabetes in African Americans Consortium.

PLoS Genet. 2014 Aug 7;10(8):e1004517. doi: 10.1371/journal.pgen.1004517. eCollection 2014 Aug.

33.

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.

Langefeld CD, Divers J, Pajewski NM, Hawfield AT, Reboussin DM, Bild DE, Kaysen GA, Kimmel PL, Raj DS, Ricardo AC, Wright JT Jr, Sedor JR, Rocco MV, Freedman BI; Systolic Blood Pressure Intervention Trial (SPRINT).

Kidney Int. 2015 Jan;87(1):169-75. doi: 10.1038/ki.2014.254. Epub 2014 Jul 16.

34.

Kidney disease: new technologies translate mechanisms to cure.

O'Toole JF, Sedor JR.

J Clin Invest. 2014 Jun;124(6):2294-8. doi: 10.1172/JCI76825. Epub 2014 Jun 2. Review.

35.

A genome-wide search for linkage of estimated glomerular filtration rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND).

Thameem F, Igo RP Jr, Freedman BI, Langefeld C, Hanson RL, Schelling JR, Elston RC, Duggirala R, Nicholas SB, Goddard KA, Divers J, Guo X, Ipp E, Kimmel PL, Meoni LA, Shah VO, Smith MW, Winkler CA, Zager PG, Knowler WC, Nelson RG, Pahl MV, Parekh RS, Kao WH, Rasooly RS, Adler SG, Abboud HE, Iyengar SK, Sedor JR; Family Investigation of Nephropathy and Diabetes Research Group.

PLoS One. 2013 Dec 17;8(12):e81888. doi: 10.1371/journal.pone.0081888. eCollection 2013.

36.

Plasma apolipoprotein L1 levels do not correlate with CKD.

Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC.

J Am Soc Nephrol. 2014 Mar;25(3):634-44. doi: 10.1681/ASN.2013070700. Epub 2013 Nov 14.

37.

The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional review.

Bodas P, Huang A, O'Riordan MA, Sedor JR, Dell KM.

BMC Nephrol. 2013 Oct 30;14:237. doi: 10.1186/1471-2369-14-237.

38.

Diabetic nephropathy: a national dialogue.

Breyer MD, Coffman TM, Flessner MF, Fried LF, Harris RC, Ketchum CJ, Kretzler M, Nelson RG, Sedor JR, Susztak K; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2013 Sep;8(9):1603-5. doi: 10.2215/CJN.03640413. Epub 2013 Jun 20.

39.

Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study.

Gunzler D, Bleyer AJ, Thomas RL, O'Brien A, Russell GB, Sattar A, Iyengar SK, Thomas C, Sedor JR, Schelling JR.

BMC Nephrol. 2013 Jun 17;14:124. doi: 10.1186/1471-2369-14-124.

40.

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.

Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M.

Kidney Int. 2013 Apr;83(4):749-56. doi: 10.1038/ki.2012.428. Epub 2013 Jan 16.

41.

Wtip and Vangl2 are required for mitotic spindle orientation and cloaca morphogenesis.

Bubenshchikova E, Ichimura K, Fukuyo Y, Powell R, Hsu C, Morrical SO, Sedor JR, Sakai T, Obara T.

Biol Open. 2012 Jun 15;1(6):588-96. doi: 10.1242/bio.20121016. Epub 2012 May 4.

42.

GWAS of diabetic nephropathy: is the GENIE out of the bottle?

Böger CA, Sedor JR.

PLoS Genet. 2012 Sep;8(9):e1002989. doi: 10.1371/journal.pgen.1002989. Epub 2012 Sep 20. No abstract available.

43.

Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.

El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M, Sedor JR.

BMC Nephrol. 2012 Jul 19;13:61. doi: 10.1186/1471-2369-13-61.

44.

Family history and kidney disease.

Drawz PE, Sedor JR, Hostetter TH.

Am J Kidney Dis. 2012 Jan;59(1):9-10. doi: 10.1053/j.ajkd.2011.11.012. No abstract available.

PMID:
22177445
45.

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Bostrom MA, Kao WH, Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL, Nicholas SB, Rasooly RS, Sedor JR, Coresh J, Kohn OF, Leehey DJ, Thornley-Brown D, Bottinger EP, Lipkowitz MS, Meoni LA, Klag MJ, Lu L, Hicks PJ, Langefeld CD, Parekh RS, Bowden DW, Freedman BI; Family Investigation of Nephropathy and Diabetes (FIND) Research Group.

Am J Kidney Dis. 2012 Feb;59(2):210-21. doi: 10.1053/j.ajkd.2011.09.020. Epub 2011 Nov 25.

46.

Use of diffusion tensor MRI to identify early changes in diabetic nephropathy.

Lu L, Sedor JR, Gulani V, Schelling JR, O'Brien A, Flask CA, MacRae Dell K.

Am J Nephrol. 2011;34(5):476-82. doi: 10.1159/000333044. Epub 2011 Oct 18.

47.

A systems view of genetics in chronic kidney disease.

Keller BJ, Martini S, Sedor JR, Kretzler M.

Kidney Int. 2012 Jan;81(1):14-21. doi: 10.1038/ki.2011.359. Epub 2011 Oct 19. Review.

48.

APOL1 localization in normal kidney and nondiabetic kidney disease.

Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR.

J Am Soc Nephrol. 2011 Nov;22(11):2119-28. doi: 10.1681/ASN.2011010069. Epub 2011 Oct 13.

49.

WT1-interacting protein (Wtip) regulates podocyte phenotype by cell-cell and cell-matrix contact reorganization.

Kim JH, Mukherjee A, Madhavan SM, Konieczkowski M, Sedor JR.

Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F103-15. doi: 10.1152/ajprenal.00419.2011. Epub 2011 Sep 7.

50.

Identification of the nephropathy-susceptibility locus HIVAN4.

Prakash S, Papeta N, Sterken R, Zheng Z, Thomas RL, Wu Z, Sedor JR, D'Agati VD, Bruggeman LA, Gharavi AG.

J Am Soc Nephrol. 2011 Aug;22(8):1497-504. doi: 10.1681/ASN.2011020209. Epub 2011 Jul 22.

Supplemental Content

Loading ...
Support Center